RESMED INC — Director's Dealing 2024

Nov 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-07

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-07	ResMed Common Stock	M	14683	$84.98	Acquired	478937	Direct
2024-11-07	ResMed Common Stock	S	14683	$246.259	Disposed	464254	Direct
2024-11-11	ResMed Common Stock	F	3101.376	$252.38	Disposed	461152	Direct
2024-11-11	ResMed Common Stock	F	2226.863	$252.38	Disposed	458925	Direct
2024-11-11	ResMed Common Stock	F	3452.9	$252.38	Disposed	455472	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-07	ResMed Common Stock Options	$84.98	M	14683	Disposed	2024-11-16	ResMed Common Stock (14683)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	4090	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F2: Includes 84.129 shares of ResMed stock purchased on October 31, 2024, through the ResMed Employee Stock Purchase Plan.

F3: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F4: This transaction was executed in multiple trades at prices ranging from $244.74 - $248.38 The price reported above reflects the weighted average sale price.

F5: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.

F6: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.

F7: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.

F8: The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.

F9: Represents date options first become exercisable. Options vest 1/3 per year.